All lobbying filings
W Strategies, LLC
W Strategies, LLC filed a Q1 report for Ipsen Biopharmaceuticals, Inc. on April 18, 2026, reporting $20,000 in lobbying income.
Lobbying for Ipsen Biopharmaceuticals, Inc. · Biopharmaceutical company.
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 18, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbying activity
1
Monitored Public Law 119-21: One Big Beautiful Bill Act. Issues related to drug pricing.